Structure |
Chemical Name |
CAS |
MF |
![Rosuvastatin Impurity 54](/) |
Rosuvastatin Impurity 54 |
|
|
![Vonoprazan Fumarate Impurity 6](/CAS/20210111/GIF/2250243-23-1.gif) |
Vonoprazan Fumarate Impurity 6 |
2250243-23-1 |
C33H27F2N5O4S2 |
![3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro- 4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-7-ol](/CAS/20200401/GIF/1456538-51-4.gif) |
3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro- 4H-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-7-ol |
1456538-51-4 |
C17H25N5O5S |
![Prasugrel Impurity 15](/) |
Prasugrel Impurity 15 |
|
|
![Pregabalin Impurity 18](/CAS/20210111/GIF/1621171-19-4.gif) |
Pregabalin Impurity 18 |
1621171-19-4 |
C9H15NO2 |
![Pregabalin Impurity 23](/) |
Pregabalin Impurity 23 |
|
|
![Butylphthalide impurity](/CAS/20200401/GIF/16692-58-3.gif) |
Butylphthalide impurity |
16692-58-3 |
C12H14O2 |
![ethyl 2,5-dihydroxybenzenesulfonate](/CAS/20200401/GIF/CB94671207.gif) |
ethyl 2,5-dihydroxybenzenesulfonate |
|
C8H10O5S |
![5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE](/CAS/GIF/24755-73-5.gif) |
5-ALLYLIDENE-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTENE |
24755-73-5 |
C18H16 |
![Nintedanib Impurity 27](/) |
Nintedanib Impurity 27 |
|
|
![ethyl 2-(2-formyl-3-hydroxyphenyl)-4-methylthiazole-5- carboxylate](/CAS/20200401/GIF/CB94676626.gif) |
ethyl 2-(2-formyl-3-hydroxyphenyl)-4-methylthiazole-5- carboxylate |
|
C14H13NO4S |
![LUMAT-004](/CAS/20200515/GIF/313544-31-9.gif) |
LUMAT-004 |
313544-31-9 |
C16H17N3O3 |
![Varenicline Impurity 3](/CAS/20210111/GIF/1333145-89-3.gif) |
Varenicline Impurity 3 |
1333145-89-3 |
C14H15N3 |
![Amlodipine Impurity 22 (Z-Isomer)](/CAS/20200401/GIF/CB94744859.gif) |
Amlodipine Impurity 22 (Z-Isomer) |
|
C26H31ClN2O8S |
![Amlodipine Impurity 28](/CAS/20200401/GIF/79781-21-8.gif) |
Amlodipine Impurity 28 |
79781-21-8 |
C18H20ClNO5 |
![Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-](/CAS/20210111/GIF/448184-48-3.gif) |
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl- |
448184-48-3 |
C23H32N6O5S |
![Dolutegravir 4-Desfluoro Impurity](/CAS/20200611/GIF/1863916-87-3.gif) |
Dolutegravir 4-Desfluoro Impurity |
1863916-87-3 |
C20H20FN3O5 |
![Tetrabenazine Dehydro Impurity](/CAS/20210305/GIF/100322-43-8.gif) |
Tetrabenazine Dehydro Impurity |
100322-43-8 |
C19H25NO3 |
![Cefotiam Impurity 22](/CAS/20210111/GIF/1628441-07-5.gif) |
Cefotiam Impurity 22 |
1628441-07-5 |
C13H14N4O5S2 |
![Dezocine Impurity 2](/CAS/20210111/GIF/100667-17-2.gif) |
Dezocine Impurity 2 |
100667-17-2 |
C16H21NO |
![loteprednol Impurity 7](/CAS/20211123/GIF/82034-20-6.gif) |
loteprednol Impurity 7 |
82034-20-6 |
C24H33ClO7 |
![Sitagliptin Impurity 28](/CAS/20210111/GIF/898543-70-9.gif) |
Sitagliptin Impurity 28 |
898543-70-9 |
C32H25F12N9O2 |
![Vilanterol Impurity 3 Triphenylacetate](/CAS/20211123/GIF/503070-62-0.gif) |
Vilanterol Impurity 3 Triphenylacetate |
503070-62-0 |
C23H31Cl2NO5 |
![Empagliflozin Impurity 33](/) |
Empagliflozin Impurity 33 |
|
|
![Sugammadex Impurity 21](/CAS/20211123/GIF/2412952-93-1.gif) |
Sugammadex Impurity 21 |
2412952-93-1 |
C72H113NaO48S8 |
![4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride](/CAS/20200401/GIF/1254176-45-8.gif) |
4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride |
1254176-45-8 |
C18H30N4O |
![3'-Deoxyneamine](/CAS/20210111/GIF/34051-04-2.gif) |
3'-Deoxyneamine |
34051-04-2 |
C12H26N4O5 |
![Remifentanil Impurity 1 (RTF-02)](/CAS/20210111/GIF/938184-94-2.gif) |
Remifentanil Impurity 1 (RTF-02) |
938184-94-2 |
C16H21N3O2 |
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
![sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate](/CAS/20200401/GIF/382140-24-1.gif) |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
![Zopiclone Impurity 13](/) |
Zopiclone Impurity 13 |
|
|
![1-Methyl-2,3-dihydroindol-2,3-dion](/CAS/GIF/2058-74-4.gif) |
1-Methyl-2,3-dihydroindol-2,3-dion |
2058-74-4 |
C9H7NO2 |
![1-bromo-3-(4-ethoxybenzyl)benzene](/CAS/20200401/GIF/898538-17-5.gif) |
1-bromo-3-(4-ethoxybenzyl)benzene |
898538-17-5 |
C15H15BrO |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/CAS/20200401/GIF/1318794-28-3.gif) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
1318794-28-3 |
C22H27ClO7 |
![Brivaracetam Impurity](/CAS/20210305/GIF/2432911-37-8.gif) |
Brivaracetam Impurity |
2432911-37-8 |
C11H22O3 |
![Cefminox Sodium impurity 5](/) |
Cefminox Sodium impurity 5 |
|
|
![Moxifloxacin Impurity 37](/CAS/20200611/GIF/1803729-19-2.gif) |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
![Nimodipine Impurity 12](/CAS/20200611/GIF/39562-18-0.gif) |
Nimodipine Impurity 12 |
39562-18-0 |
C19H22N2O6 |
![Rosuvastatin Impurity 53](/) |
Rosuvastatin Impurity 53 |
|
|
![Sulbactam Impurity 8](/CAS/20210111/GIF/75527-88-7.gif) |
Sulbactam Impurity 8 |
75527-88-7 |
C8H10BrNO5S |
![Tenofovir Impurity 64](/CAS/20200611/GIF/1878175-76-8.gif) |
Tenofovir Impurity 64 |
1878175-76-8 |
C13H23N5O8P2 |
![Ticagrelor Impurity 65](/) |
Ticagrelor Impurity 65 |
|
|
![Ticagrelor Impurity 72](/CAS/20210111/GIF/1402150-11-1.gif) |
Ticagrelor Impurity 72 |
1402150-11-1 |
C24H28F2N6O5S |
![Topiroxostat Impurity 18](/) |
Topiroxostat Impurity 18 |
|
|
![Amifostine Impurity 5](/CAS/20210305/GIF/712255-27-1.gif) |
Amifostine Impurity 5 |
712255-27-1 |
C5H9BrN2 |
![Aztreonam Impurity 5](/CAS/20210111/GIF/2195336-17-3.gif) |
Aztreonam Impurity 5 |
2195336-17-3 |
C4H10N2O5S |
![Canagliflozin Impurity 35](/) |
Canagliflozin Impurity 35 |
|
|
![Cefazolin Impurity 7 (Cefazolin Trimethylsilyl Ester)](/CAS/20210111/GIF/1072000-00-0.gif) |
Cefazolin Impurity 7 (Cefazolin Trimethylsilyl Ester) |
1072000-00-0 |
C17H22N8O4S3Si |
![Dapagliflozin Impurity 25](/) |
Dapagliflozin Impurity 25 |
|
|
![Doripenem Impurity 1](/) |
Doripenem Impurity 1 |
|
|
![Erlotinib Impurity 54](/) |
Erlotinib Impurity 54 |
|
|
![Erlotinib Impurity 59](/) |
Erlotinib Impurity 59 |
|
|
![Etoposide Impurity 5](/) |
Etoposide Impurity 5 |
|
|
![Olaparib Impurity 26](/) |
Olaparib Impurity 26 |
|
|
![Oseltamivir Impurity 14](/CAS/20210305/GIF/2081110-44-1.gif) |
Oseltamivir Impurity 14 |
2081110-44-1 |
C16H28N2O4 |
![Rocuronium bromide Impurity 35](/) |
Rocuronium bromide Impurity 35 |
|
|
![AZD9291 Osimertinib Impurity 1](/) |
AZD9291 Osimertinib Impurity 1 |
|
|
![Dextrorotation lansoprazole Impurity I](/) |
Dextrorotation lansoprazole Impurity I |
|
|
![Ivabradine Impurity 31](/) |
Ivabradine Impurity 31 |
|
|
![isopropyl 2-(2-oxopyrrolidin-1-yl)acetate](/CAS/20210111/GIF/1249080-59-8.gif) |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
![Pitavastatin Impurity 71](/) |
Pitavastatin Impurity 71 |
|
|
![Rosuvastatin EP Impurity M Sodium Salt](/) |
Rosuvastatin EP Impurity M Sodium Salt |
|
|
![Furosemide impurity 8](/) |
Furosemide impurity 8 |
|
|
![Febuxostat Impurity 108](/) |
Febuxostat Impurity 108 |
|
|
![Flucloxacillin EP Impurity J](/) |
Flucloxacillin EP Impurity J |
|
|
![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](/CAS/20200611/GIF/1878175-77-9.gif) |
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
![Hexanoic acid, 3-formyl-, ethyl ester](/CAS/20200611/GIF/54374-02-6.gif) |
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-](/CAS/20200611/GIF/154877-92-6.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2463617-49-2.gif) |
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide](/) |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
![Vonoprazan Impurity B-2](/) |
Vonoprazan Impurity B-2 |
|
|
![2-(Cyanomethylthio)acetic acid](/CAS/GIF/55817-29-3.gif) |
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
![Budesonide Impurity 31](/) |
Budesonide Impurity 31 |
|
|
![Budesonide Impurity 23](/) |
Budesonide Impurity 23 |
|
|
![Hexanoic acid, 3-(chloromethyl)-, (3R)-](/CAS/20210111/GIF/2101641-90-9.gif) |
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
![Bisoprolol Impurity](/CAS/20210305/GIF/2226263-68-7.gif) |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](/CAS/20210111/GIF/1261219-83-3.gif) |
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
![Tofacitinib Impurity](/CAS/20211123/GIF/2504210-41-5.gif) |
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
![tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate](/) |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
![(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)](/CAS/20211123/GIF/96946-55-3.gif) |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
![Glycine, N-(2-aminobenzoyl)-, ethyl ester](/CAS/20210305/GIF/5973-34-2.gif) |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![Hexahydrocyclopenta[c]pyrrol-2(1H)-amin](/CAS/GIF/54528-00-6.gif) |
Hexahydrocyclopenta[c]pyrrol-2(1H)-amin |
54528-00-6 |
C7H14N2 |
![(S)-Methyl 2-aminobutanoate](/CAS/GIF/15399-22-1.gif) |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
![(3aS-cis)-1,3-Dibenzyltetrahydro-1H-thieno[3,4-d]imidazol-2,4-dion](/CAS/GIF/28092-52-6.gif) |
(3aS-cis)-1,3-Dibenzyltetrahydro-1H-thieno[3,4-d]imidazol-2,4-dion |
28092-52-6 |
C19H18N2O2S |
![Methyl-L-prolinat](/CAS/GIF/2577-48-2.gif) |
Methyl-L-prolinat |
2577-48-2 |
C6H11NO2 |
![sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate](/) |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
![2,4,6-tripropyl-1,3,5-trioxane](/CAS/GIF/2396-43-2.gif) |
2,4,6-tripropyl-1,3,5-trioxane |
2396-43-2 |
C12H24O3 |
![Oseltamivir Impurity 94](/) |
Oseltamivir Impurity 94 |
|
|
![Oseltamivir Impurity 82](/) |
Oseltamivir Impurity 82 |
|
|
![Oseltamivir Impurity 74](/) |
Oseltamivir Impurity 74 |
|
|
![Uridine, 5'-(2-methylpropanoate) (9CI)](/CAS/20210305/GIF/886538-48-3.gif) |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
![Dapagliflozin Impurity 47](/) |
Dapagliflozin Impurity 47 |
|
|
![Crisaborole Impurity 17](/) |
Crisaborole Impurity 17 |
|
|
![Crisaborole Impurity 19](/) |
Crisaborole Impurity 19 |
|
|